Clinical Trial Update: Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

View source ↗

Summary

A clinical trial investigating multiparametric MRI as a non-invasive biomarker of the tumor microenvironment in breast cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Laura Kennedy | Conditions: Breast Cancer, Triple-negative Breast Cancer | Status: SUSPENDED